Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

Sickle cell and silent spleen.

Tolar J.

Blood. 2015 Apr 23;125(17):2589-90. doi: 10.1182/blood-2015-03-633933. No abstract available.

PMID:
25907900
2.

Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children With Recessive Dystrophic Epidermolysis Bullosa.

Petrof G, Lwin SM, Martinez-Queipo M, Abdul-Wahab A, Tso S, Mellerio JE, Slaper-Cortenbach I, Boelens JJ, Tolar J, Veys P, Ofuya M, Peacock JL, Martinez AE, McGrath JA.

J Invest Dermatol. 2015 Apr 23. doi: 10.1038/jid.2015.158. [Epub ahead of print] No abstract available.

PMID:
25905587
3.

From Marrow to Matrix: Novel Gene and Cell Therapies for Epidermolysis Bullosa.

Webber BR, Tolar J.

Mol Ther. 2015 Mar 24. doi: 10.1038/mt.2015.47. [Epub ahead of print] Review.

PMID:
25803200
4.

Placenta-based therapies for the treatment of epidermolysis bullosa.

Nevala-Plagemann C, Lee C, Tolar J.

Cytotherapy. 2015 Mar 17. pii: S1465-3249(15)00090-0. doi: 10.1016/j.jcyt.2015.03.006. [Epub ahead of print] Review.

PMID:
25795271
5.

The three-body problem of therapy with induced pluripotent stem cells.

Tolar J, McGrath JA.

Genome Med. 2015 Feb 20;7(1):15. doi: 10.1186/s13073-015-0141-7. eCollection 2015.

6.

Alternative donor transplant of benign primary hematologic disorders.

Tolar J, Sodani P, Symons H.

Bone Marrow Transplant. 2015 Feb 9. doi: 10.1038/bmt.2015.1. [Epub ahead of print] Review.

PMID:
25665040
7.

A living band-aid for epidermolysis bullosa.

Tolar J, Tolar M.

Blood Transfus. 2015 Jan;13(1):1-2. doi: 10.2450/2014.0289-14. No abstract available.

8.

Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study.

Aldenhoven M, Wynn RF, Orchard PJ, O'Meara A, Veys P, Fischer A, Valayannopoulos V, Neven B, Rovelli A, Prasad VK, Tolar J, Allewelt H, Jones SA, Parini R, Renard M, Bordon V, Wulffraat NM, de Koning TJ, Shapiro EG, Kurtzberg J, Boelens JJ.

Blood. 2015 Mar 26;125(13):2164-72. doi: 10.1182/blood-2014-11-608075. Epub 2015 Jan 26.

PMID:
25624320
9.

A biologic Velcro patch.

Tolar J, Wagner JE.

N Engl J Med. 2015 Jan 22;372(4):382-4. doi: 10.1056/NEJMcibr1414709. No abstract available.

PMID:
25607432
10.

Fanconi anemia gene editing by the CRISPR/Cas9 system.

Osborn MJ, Gabriel R, Webber BR, DeFeo AP, McElroy AN, Jarjour J, Starker CG, Wagner JE, Joung JK, Voytas DF, von Kalle C, Schmidt M, Blazar BR, Tolar J.

Hum Gene Ther. 2015 Feb;26(2):114-26. doi: 10.1089/hum.2014.111.

PMID:
25545896
11.

The individual (single patient) IND for inborn errors of metabolism.

Dickson PI, Tolar J.

Mol Genet Metab. 2014 Oct 13. pii: S1096-7192(14)00312-6. doi: 10.1016/j.ymgme.2014.10.003. [Epub ahead of print]

PMID:
25456747
12.

Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa.

Mack MR, Wendelschafer-Crabb G, McAdams BD, Hordinsky MK, Kennedy WR, Tolar J.

J Invest Dermatol. 2015 Apr;135(4):1193-7. doi: 10.1038/jid.2014.500. Epub 2014 Nov 14. No abstract available.

PMID:
25431850
13.

Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast.

Zhang L, Guo J, Zhang P, Xiong Q, Wu SC, Xia L, Roy SS, Tolar J, O'Connell TD, Kyba M, Liao K, Zhang J.

Circ Heart Fail. 2015 Jan;8(1):156-66. doi: 10.1161/CIRCHEARTFAILURE.114.001317. Epub 2014 Nov 24.

PMID:
25420485
14.

Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa.

Perdoni C, McGrath JA, Tolar J.

Stem Cell Res Ther. 2014 Nov 6;5(6):121. doi: 10.1186/scrt511.

PMID:
25376815
15.

An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomes.

Ross JA, Tolar J, Spector LG, DeFor T, Lund TC, Weisdorf DJ, Langer E, Hooten AJ, Thyagarajan B, Gleason MK, Wagner JE, Robien K, Verneris MR.

Biol Blood Marrow Transplant. 2015 Jan;21(1):81-8. doi: 10.1016/j.bbmt.2014.09.023. Epub 2014 Oct 6.

PMID:
25300867
16.

MSC therapy attenuates obliterative bronchiolitis after murine bone marrow transplant.

Raza K, Larsen T, Samaratunga N, Price AP, Meyer C, Matson A, Ehrhardt MJ, Fogas S, Tolar J, Hertz MI, Panoskaltsis-Mortari A.

PLoS One. 2014 Oct 1;9(10):e109034. doi: 10.1371/journal.pone.0109034. eCollection 2014.

17.

Augmentation of cutaneous wound healing by pharmacologic mobilization of endogenous bone marrow stem cells.

Tolar J, McGrath JA.

J Invest Dermatol. 2014 Sep;134(9):2312-4. doi: 10.1038/jid.2014.209.

PMID:
25120149
18.

Incidence of intracranial germ cell tumors by race in the United States, 1992-2010.

Poynter JN, Fonstad R, Tolar J, Spector LG, Ross JA.

J Neurooncol. 2014 Nov;120(2):381-8. doi: 10.1007/s11060-014-1562-7. Epub 2014 Aug 3.

PMID:
25086758
19.

sdf1 Expression reveals a source of perivascular-derived mesenchymal stem cells in zebrafish.

Lund TC, Patrinostro X, Kramer AC, Stadem P, Higgins LA, Markowski TW, Wroblewski MS, Lidke DS, Tolar J, Blazar BR.

Stem Cells. 2014 Oct;32(10):2767-79. doi: 10.1002/stem.1758.

PMID:
24905975
20.

Advances in understanding and treating dystrophic epidermolysis bullosa.

Vanden Oever MJ, Tolar J.

F1000Prime Rep. 2014 May 6;6:35. doi: 10.12703/P6-35. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk